Baxter International Inc. (BAX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Baxter International ( BAX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.7%. By the end of trading, Baxter International fell $0.82 (-1.2%) to $68.66 on average volume. Throughout the day, 2,415,626 shares of Baxter International exchanged hands as compared to its average daily volume of 3,178,500 shares. The stock ranged in price between $68.58-$69.47 after having opened the day at $69.47 as compared to the previous trading day's close of $69.48. Other companies within the Health Services industry that declined today were: Tenet Healthcare ( THC), down 9.1%, SunLink Health Systems ( SSY), down 8.8%, Amedica Corporation ( AMDA), down 8.5% and Dehaier Medical Systems ( DHRM), down 7.0%.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $37.6 billion and is part of the health care sector. Shares are down 0.1% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Baxter International a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, Spectranetics Corporation ( SPNC), up 15.1%, ImmunoCellular Therapeutics ( IMUC), up 14.1%, Kips Bay Medical ( KIPS), up 5.5% and TearLab Corpoartion ( TEAR), up 4.6% , were all gainers within the health services industry with Boston Scientific ( BSX) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Global Stocks Hold Gains as North Korea Response on Talks Soothes Nerves

Global Stocks Hold Gains as North Korea Response on Talks Soothes Nerves

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists